230 results on '"Simon, Dagmar"'
Search Results
2. PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis
3. Characteristics of Dermatological Patients With Blood Eosinophilia: A Retrospective Analysis of 453 Patients
4. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes
5. Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders
6. Differential diagnosis of contact dermatitis: A practical‐approach review by the EADV Task Force on contact dermatitis.
7. Crossing Borders, Creating Together : An Interdisciplinary Dialogue on Transdisciplinary Knowledge Production
8. Evidence for Lysosomal Dysfunction within the Epidermis in Psoriasis and Atopic Dermatitis
9. Dupilumab normalizes correlates of lysosomal function in atopic dermatitis.
10. Disease Progression and Outcomes of Pregnancies in Women With Eosinophilic Esophagitis
11. The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies
12. Therapeutic strategies for eosinophilic dermatoses
13. Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
14. Dupilumab‐associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation.
15. S3‐Leitlinie Atopische Dermatitis: Teil 2 ‐ Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 ‐ Systemic treatment.
16. S3 guideline Atopic dermatitis: Part 2 ‐ Systemic treatment.
17. From “living lab” to strategic action field: Bringing together energy, mobility, and Information Technology in Germany
18. S3‐Leitlinie Atopische Dermatitis: Teil 1‐ Allgemeine Aspekte, topische und nichtmedikamentöse Therapien, besondere Patientengruppen: S3 guideline Atopic dermatitis: Part 1‐ General aspects, topical and non‐drug therapies, special patient groups
19. S3 Guideline Atopic dermatitis: Part 1 ‐ General aspects, topical and non‐drug therapies, special patient groups.
20. Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.
21. Eosinophils—from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion.
22. Eosinophilia in Dermatologic Disorders
23. One Site—Multiple Visions: Visioneering Between Contrasting Actors’ Perspectives
24. Elevated levels of the antimicrobial peptide LL‐37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response
25. Eosinophils as putative therapeutic targets in bullous pemphigoid
26. Plain Language Summary of principles for improving the care of people with eosinophil-associated diseases.
27. Eosinophils from A to Z.
28. Difficult to control atopic dermatitis
29. „Vielfältige“ Organisationen: Der Wissens- und Technologietransfer als Herausforderung für die außeruniversitäre Forschung
30. Occupational contact allergy: The European perspective–Analysis of patch test data from ESSCA between 2011 and 2020.
31. Akademische Unternehmensgründungen: Über den schwierigen Nachweis der Nützlichkeit öffentlicher Forschungsförderung
32. EDITORIAL: Leviathan 3/2010
33. Skin redness index: A new practical method for unbiased automated quantification of skin redness.
34. Eosinophil extracellular DNA traps in skin diseases
35. Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis
36. Contact sensitizations in massage therapists with occupational contact dermatitis: Patch test data of the Information Network of Departments of Dermatology, 2008–2020.
37. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
38. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract
39. Patch test results in children and adolescents across Europe. Analysis of the ESSCA Network† 2002–2010
40. Wissenschaftliches Publizieren: Auf dem Weg zu einer neuen Bewertungspraxis?
41. Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC.
42. Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses?
43. Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study.
44. Anti-CD20 (rituximab) treatment improves atopic eczema
45. Decoding atopic dermatitis: unveiling phenotypes through data-driven methods.
46. Unübersichtlichkeiten in der Forschungslandschaft: Neue Aufgaben und alte Probleme einer Wissenschaftspolitik
47. Improving Care in Eosinophil-Associated Diseases: A Charter.
48. Is benzyl alcohol a significant contact sensitizer?
49. White Paper on Gaps, Overlaps, and Opportunities in View of the Extension of Bilateral RTD Programmes and Initiatives towards Multilateral Approaches
50. 2,4,6‐Tris(dimethylaminomethyl)phenol: The allergen which came in from the cold.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.